FindTrial
Sign In

A clinical study for CRE continous screening in patients with hematopoietic stem cell transplantation

A clinical study for CRE continous screening in patients with hematopoietic stem cell transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025785
Enrollment
Unknown
Registered
2019-09-08
Start date
2019-08-23
Completion date
Unknown
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carbapenem-resistant Enterobacteriaceae bacterial infection

Interventions

Case series:None

Sponsors

The First Affiliated Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The informed consent is signed by the subjects or their legal representatives before the start of clinical research; 2. Diagnosis of hematological malignancies and acceptance of hematopoietic stem cell transplantation.

Exclusion criteria

Exclusion criteria: 1. CRE infection is confirmed before hematopoietic stem cell transplantation; 2. failure to perform anal test.

Design outcomes

Primary

MeasureTime frame
the rate of CRE;the rate of CRE infection ;CRE mortality;—

Countries

China

Contacts

Public ContactJimin Shi

The First Affiliated Hospital of Zhejiang University School of Medicine

Jiminshi@126.com+86 13857119077

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026